Informação sobre produto
- N-(4-Methyl-2-thiazolyl)-2-[(6-phenyl-3-pyridazinyl)thio]-acetamide
VU0240551 is a novel, potent, and selective allosteric modulator of the GABA receptor. It has been shown to have an excitatory effect in animal models of epilepsy and depression. VU0240551 has been shown to act as an allosteric modulator of α5-containing GABAA receptors, but not α1- or α2-containing GABAA receptors. This drug also potently increased chloride transport rates in mouse hippocampal neurons without affecting sodium or potassium transport rates. It has been proposed that this drug may be used for the treatment of seizures, depression, and chronic pain.
VU0240551 is currently being evaluated for its efficacy as a therapeutic agent for the treatment of epilepsy and depression by a Phase 2 clinical trial (NCT02696679).
Propriedades químicas
Consulta técnica sobre: 3D-TKB99034 VU0240551
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
